The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome.


No votes yet
 
Related
The Community of Madrid has declared this project to be strategic: it will create 200 new direct jobs for 2027 and raise the plant’s...
4 min
11/07/2024
​ The company will be submitting for the approval of the Ordinary General Shareholders’ Meeting the annual accounts for the financial...
9 min
24/06/2024
​The new facility has meant an investment of 11 million euros This new line, which has now been authorised to commence commercial...
3 min
20/06/2024